About
As President of GSK Global Vaccines, Roger Connor oversees an industry-leading enterprise delivering vaccines to over 160 countries and more than £5 billion in turnover. Roger has been a member of the Corporate Executive Team since 2013 and was appointed to his current role on 1 September 2018. GSK Vaccines has a broad portfolio of more than 40 vaccines and a robust pipeline of 14 candidate vaccines in development. The Vaccines team is made up of over 17,000 employees across 11 countries working to deliver more than 2 million doses every day to help protect people throughout life all around the world. In addition to his Vaccines duties, he is responsible for GSK’s global procurement organisation. Previously, Roger was President, Global Manufacturing & Supply (GMS), leading an organisation of over 30,000 people, and a network of over 60 Pharmaceutical and Consumer Healthcare manufacturing sites. He also led Procurement, Product Quality, and Environment, Health, Safety & Sustainabilit
Position in the VCSift Database
- • 4 investors at GSK are tracked.
- • 1 investors hold the President, Global Manufacturing & Supply role in VCSift. Roger Connor is one of them.
- • 26 investors are based in Eden Prairie, Minnesota, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Eden Prairie, US
Contact Information
Find more investors like Roger
Search Investors